1.
Cao R, Du W, Lin B. Comparison and Synergy of iVAC and CRISPR-Related Tumor Immune Strategies: Value Reassessment Under A Zero Genome Risk Reference. IJBLS [Internet]. 2026 Nov. 15 [cited 2026 Nov. 17];17(2):44-51. Available from: https://drpress.org/ojs/index.php/ijbls/article/view/36392